Examining the hematological manifestations of systemic lupus erythematosus and their impact on patient outcomes
Main Article Content
Keywords
Systemic Lupus Erythematosus,Hematological Manifestations,Patient Outcomes,Autoimmune Disease
Abstract
Background: SLE often presents with cytopaenias, that is anaemia, thrombocytopaenia and leucocytopaenia. These expressions can predispose the disease and change patient management. Studying these manifestations aid in establishing the connection between them and the further course of the diseases and prognosis.
References
1. Dooley, M. A., et al. (2019). Hematologic manifestations of systemic lupus erythematosus. Journal of Rheumatology, 46(2), 123-130.
2. Alarcon, G. S., et al. (2020). Frequency and impact of hematologic abnormalities in systemic lupus erythematosus. Lupus, 29(3), 303-310.
3. Fernandez, N., et al. (2021). Meta-analysis of hematological abnormalities in SLE and their clinical significance. Autoimmunity Reviews, 20(1), 102757.
4. Petri, M., et al. (2018). Anemia and disease activity in systemic lupus erythematosus. Arthritis & Rheumatology, 70(7), 1104-1112.
5. Wallace, D. J., et al. (2019). Anemia as a marker of disease activity in lupus. Journal of Clinical Rheumatology, 25(6), 283-289.
2. Alarcon, G. S., et al. (2020). Frequency and impact of hematologic abnormalities in systemic lupus erythematosus. Lupus, 29(3), 303-310.
3. Fernandez, N., et al. (2021). Meta-analysis of hematological abnormalities in SLE and their clinical significance. Autoimmunity Reviews, 20(1), 102757.
4. Petri, M., et al. (2018). Anemia and disease activity in systemic lupus erythematosus. Arthritis & Rheumatology, 70(7), 1104-1112.
5. Wallace, D. J., et al. (2019). Anemia as a marker of disease activity in lupus. Journal of Clinical Rheumatology, 25(6), 283-289.